Zoekresultaten - 25 results
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
meeting the definition of immunocompromised conditions (from January 24, 2022) and to people who had received the Jcovden vaccine (Johnson&Johnson®) as a primary COVID-19 vaccination schedule (from ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
Marleen G Van de Sande; Steven Van Gucht; Martin P Grobusch; Abraham Goorhuis Source: J Travel Med (2022) Abstract: BACKGROUND: For immunocompromised patients (ICP s), administration of rabies ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Stéphanie Humblet-Baron Source: Front Immunol, Volume 13 (2022) Keywords: 2019-nCoV Vaccine mRNA-1273 Antibodies, Viral BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunocompromised Host mRNA Vaccines ...
QuilA-Adjuvanted T. gondii Lysate Antigens Trigger Robust Antibody and IFNγ+ T Cell Responses in Pigs Leading to Reduction in Parasite DNA in Tissues Upon Challenge InfectionImage
toxoplasmosis. In healthy individuals T. gondii infections mostly remain asymptomatic, however this parasite causes severe morbidity and mortality in immunocompromised patients and congenital toxoplasmosis in ...
Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections.
Marijke Hendrickx Source: Front Microbiol, Volume 10 (2019) Abstract: Invasive fungal infections, such as aspergillosis, candidiasis, and cryptococcosis, have significantly increased among immunocompromised ...
Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.
8 (2018) Keywords: antifungal resistance Candida glabrata Gene Expression genotypic identification Abstract: is a major cause of candidemia in immunocompromised patients and is characterized by a high-level ...
Very Long Persistence of Botulinum Toxin B in a Patient’s Serum
Diseases Journal, Volume 10, Issue 1, Number 191 (2018) Keywords: Bioassay BoNT Botulinum neurotoxins Botulism Clostridium botulinum Immunocompromised Abstract: Background: Botulinum toxins (BoNT) type A, B, ...
Increasing candidemia incidence from 2004 to 2015 with a shift in epidemiology in patients pre-exposed to antifungals.
Mycoses, Number 7 (2017) Keywords: Antifungal Agents Candida spp. candidaemia epidemiology incidence Abstract: BACKGROUND: Candidemia is an important health problem in immunocompromised patients with an ...
Belgian Wildlife as Potential Zoonotic Reservoir of Hepatitis E Virus.
Dis, Volume 64, Issue 3, p.764-773 (2017) Abstract: Hepatitis E is an acute human liver disease in healthy individuals but may become chronic in immunocompromised patients. It is caused by the hepatitis ...
Infectious Bursal Disease: a complex host-pathogen interaction.
Keywords: Animals Antibodies, Viral B-Lymphocytes Birnaviridae Infections Bursa of Fabricius Chickens Cytokines Host-Pathogen Interactions Immunity, Innate Immunocompromised Host Infectious bursal disease ...